Drug Repurposing Market: Global Market Growth, Trends & Forecast

The Drug Repurposing Market is becoming an increasingly important area of pharmaceutical research as companies seek faster and more cost-effective approaches to developing new treatments. Drug repurposing involves identifying new therapeutic applications for existing drugs, potentially reducing development time and leveraging previously established safety information.

According to Market Research Future, the global market was valued at approximately USD 39.2 billion in 2025 and is projected to reach USD 52.8 billion by 2035, representing a CAGR of 3.1% during 2026–2035.

The market is being supported by growing pharmaceutical R&D costs, patent expirations, advances in artificial intelligence, computational drug discovery, and increasing interest in treatments for rare and orphan diseases.

North America currently represents a major share of the market, while Asia-Pacific is expected to experience strong growth due to expanding clinical-trial infrastructure and pharmaceutical research capabilities.

The increasing adoption of AI-powered screening, real-world evidence, and network pharmacology is expected to further transform drug repurposing strategies over the coming years.

Read More
Lukoon https://lukoon.com